Inspiring transformational change in the

field of oncology diagnostics


To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies

Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

Latest News


- 22 hours ago

In as little as 3 hours, #ADXBLADDER can provide very accurate and reliable diagnostic results. Find out more about…

- 2 days ago

Today we joined Dr Stuart McCracken to see the data presented in "A novel non-invasive aid for bladder cancer diagn…

- 3 days ago

Go behind the scenes of the #nebusinessawards with these great snaps on the Chronicle Live website. Check out the f…